A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B
- 1 November 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (9), 3035-3042
- https://doi.org/10.1182/blood-2005-03-1153
Abstract
Von Willebrand factor (VWF) is unable to interact spontaneously with platelets because this interaction requires a conversion of the VWF A1 domain into a glycoprotein Ibα (GpIbα) binding conformation. Here, we discuss a llama-derived antibody fragment (AU/VWFa-11) that specifically recognizes the GpIbα-binding conformation. AU/VWFa-11 is unable to bind VWF in solution, but efficiently interacts with ristocetin- or botrocetin-activated VWF, VWF comprising type 2B mutation R1306Q, or immobilized VWF. These unique properties allowed us to use AU/VWFa-11 for the detection of activated VWF in plasma of patients characterized by spontaneous VWF-platelet interactions: von Willebrand disease (VWD) type 2B and thrombotic thrombocytopenic purpura (TTP). For VWD type 2B, levels of activated VWF were increased 12-fold (P < .001) compared to levels in healthy volunteers. An inverse correlation between activated VWF levels and platelet count was observed (R2 = 0.74; P < .003). With regard to TTP, a 2-fold (P < .001) increase in activated VWF levels was found in plasma of patients with acquired TTP, whereas an 8-fold increase (P < .003) was found in congenital TTP. No overlap in levels of activated VWF could be detected between acquired and congenital TTP, suggesting that AU/VWFa-11 could be used to distinguish between both disorders. Furthermore, it could provide a tool to investigate the role of VWF in the development of thrombocytopenia in various diseases.Keywords
This publication has 25 references indexed in Scilit:
- Von Willebrand factor, platelets and endothelial cell interactionsJournal of Thrombosis and Haemostasis, 2003
- Von Willebrand factorCurrent Opinion in Hematology, 2003
- ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditionsBlood, 2002
- Structures of Glycoprotein Ibα and Its Complex with von Willebrand Factor A1 DomainScience, 2002
- Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezersBlood, 2002
- Purification of human von Willebrand factor–cleaving protease and its identification as a new member of the metalloproteinase familyBlood, 2001
- BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTORAnnual Review of Biochemistry, 1998
- Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand FactorCell, 1996
- Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complexBiochemistry, 1988
- Heightened Interaction between Platelets and Factor VIII/von Willebrand Factor in a New Subtype of von Willebrand's DiseaseNew England Journal of Medicine, 1980